close
MENU
Hot Topic Budget 25
How to guide
How to guide
Home
NBR Marketplace
The NBR List
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

The NBR Podcast Morning Brew The Grind Entrepreneurs Your Business Beehive Banter Toil & Trouble Market Outlook Dollars & Sense Local Edge Private Bin Audio Articles Podcasts NZ Aviation News Back Issues NBR Radar (Archive) Opinion (Archive) NBR Rich List (Archive)
Hot Topic Budget 25
General Business
5 mins to read
2

Noteholders seize control as Cannasouth tips into receivership

Shareholders who invested around $30m will lose the lot, although the company’s subsidiaries will keep trading.

Fiona Rotherham Thu, 22 May 2025

Former NZX-listed Cannasouth has been put into receivership, a year after going into voluntary administration when the medicinal cannabis company ran out of money.

Kevin Davies of Principle Insolvency in Hamilton has been appointed as receiver.

Interim CEO David Petterson said in an email to

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Already have an account? Login
Fiona Rotherham Thu, 22 May 2025
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
medicinal cannabis Cannasouth David Petterson Eqalis Pharmaceuticals Greenfern Industries Aether Pacific Pharmaceuticals Rua Bioscience Helius Therapeutics

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Related News
Shoeshine
3

Winners and losers in NZ’s medicinal cannabis market
Investment
2

Listed medicinal cannabis firm Greenfern in receivership
General Business
3

Medical Kiwi placed into administration

Shoeshine
1

The Cannasouth turnaround – can it be saved?
General Business
2

New Zealand’s medicinal cannabis sector at inflection point

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Related News
Shoeshine
3

Winners and losers in NZ’s medicinal cannabis market
Investment
2

Listed medicinal cannabis firm Greenfern in receivership
General Business
3

Medical Kiwi placed into administration

Shoeshine
1

The Cannasouth turnaround – can it be saved?
General Business
2

New Zealand’s medicinal cannabis sector at inflection point
Noteholders seize control as Cannasouth tips into receivership
General Business,
108888
true
Subscribe Login